Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women

International Journal of Cancer

Volumn 132, Issue 2, 2013, Pages 327-334

  Hosaka, Masayoshi ^a   Fujita, Hiromasa ^b   Hanley, Sharon J B ^a   Sasaki, Takayuki ^b   Shirakawa, Yozo ^b   Abiko, Mitsuharu ^b   Kudo, Masataka ^a   Kaneuchi, Masanori ^a   Watari, Hidemichi ^a   Kikuchi, Kohkichi ^b   Sakuragi, Noriaki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Hokkaido Cancer Society   (Japan)

Author keywords

cervical cancer; cervical intraepithelial neoplasia 2 (CIN2); genotyping; human papillomavirus; progression

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INCIDENCE; CYTOPATHOLOGY; DISEASE SEVERITY; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; JAPANESE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOTYPE; HUMANS; INCIDENCE; JAPAN; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; MULTIVARIATE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84869488609     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27680     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
3. Bouvard V, Baan R, Straif K, et al.; WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009; 10: 321-2.
4. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007; 121: 621-32.
5. Wright TC, Jr, Massad LS, Dunton CJ, et al. 2006 Consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. Am J Obstet Gynecol 2007; 197: 340-5. Review.
6. Castle PE, Schiffman M, Wheeler CM, et al. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 2009; 113: 18-25.
7. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, et al. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006; 367: 489-98. Review.
8. Ostör AG,. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12: 186-92. Review.
9. Kataja V, Syrjänen K, Mäntyjärvi R, et al. Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data. Eur J Epidemiol 1989; 5: 1-7.
10. Ioka A, Tsukuma H, Ajiki W, et al. Influence of age on cervical cancer survival in Japan. Jpn J Clin Oncol 2005; 35: 464-9.
11. Gaarenstroom KN, Melkert P, Walboomers JM, et al. Human papillomavirus DNA and genotypes: prognostic factors for progression of cervical intraepithelial neoplasia. Int J Gynecol Cancer 1994; 4: 73-8.
12. Remmink AJ, Walboomers JM, Helmerhorst TJ, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995; 61: 306-11.
13. Muñoz N, Bosch FX, Castellsagué X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111: 278-85.
14. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005; 97: 1072-9.
15. Xi LF, Hughes JP, Edelstein ZR, et al. Human papillomavirus (HPV) type 16 and type 18 DNA loads at baseline and persistence of type-specific infection during a 2-year follow-up. J Infect Dis 2009; 200: 1789-97.
16. Matsumoto K, Oki A, Furuta R, et al.; for Japan HPV And Cervical Cancer (JHACC) Study Group. Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study. Int J Cancer 2010; 128: 2898-910.
17. Yamaguchi A, Hashimoto N, Tsutae W, et al. Detection of human papillomavirus DNA by PCR/microfluorometry for screening of cervical cancer. Clin Chim Acta 2002; 318: 41-9.
18. Onuki M, Matsumoto K, Satoh T, et al. Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer. Cancer Sci 2009; 100: 1312-6.
19. Fujinaga Y, Shimada M, Okazawa K, et al. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 1991; 72: 1039-44.
20. Clifford GM, Gallus S, Herrero R, et al.; IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991-8.
21. Zhao R, Zhang WY, Wu MH, et al. Human papillomavirus infection in Beijing, People's Republic of China: a population-based study. Br J Cancer 2009; 101: 635-40.
22. Bao YP, Li N, Smith JS, et al. Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 2008; 18: 71-9.
23. Schlecht NF, Platt RW, Duarte-Franco E, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 2003; 95: 1336-43.
24. Evans MF, Adamson CS, Papillo JL, et al. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 2006; 106: 1054-64.
25. Illades-Aguiar B, Alarcõn-Romero Ldel C, Antonio-Véjar V, et al. Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico. Gynecol Oncol 2010; 117: 291-6.
26. Miura S, Matsumoto K, Oki A, et al. Do we need a different strategy for HPV screening and vaccination in East Asia? Int J Cancer 2006; 119: 2713-15.
27. Qu W, Jiang G, Cruz Y, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997; 35: 1304-10.
28. Yoshikawa H, Nagata C, Noda K, et al. Human papillomavirus infection and other risk factors for cervical intraepithelial neoplasia in Japan. Br J Cancer 1999; 80: 621-4.
29. Sasagawa T, Basha W, Yamazaki H, et al. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 2001; 10: 45-52.
30. Spinillo A, Dal Bello B, Gardella B, et al. Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. Gynecol Oncol 2009; 113: 115-19.
31. Muñoz N, Bosch FX, de Sanjosé S, et al.; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
32. ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology. Obstet Gynecol 2008; 112: 1419-44.
33. Mathevet P, Chemali E, Roy M, et al. Long-term outcome of a randomized study comparing three techniques of conization: cold knife, laser, and LEEP. Eur J Obstet Gynecol Reprod Biol 2003; 106: 214-18.
34. Franceschi S, Clifford GM,. Re: a study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst 2005; 97: 938-9.
35. Cancer Statistics in Japan. Center for Cancer Control and Information Services, National Cancer Center of Japan. International Comparisons of Cancer Mortality and Cancer Screening Rates. http://ganjoho.jp/data/public/statistics/ backnumber/1isaao000000068m-att/fig21.pdf. Accessed on 22 April 2012.
36. Ministry of Health, Labour and Welfare. Comprehensive Survey of Living Conditions of the People on Health and Welfare 2010. http://www.mhlw.go.jp/stf/ houdou/2r9852000001igt0-att/2r9852000001iguh.pdf. Accessed on 22 April 2012.